Melanoma Brain Metastases
📧 Sign up to get email alerts when something new happens for Melanoma Brain Metastases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases [Phase 1]
Phase 1 trial evaluating stereotactic radiosurgery, NovoTTF-200M, and immune checkpoint inhibitors for melanoma brain metastases was termina…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases [Phase 2]
This clinical trial update describes a Phase 2 study evaluating bevacizumab and atezolizumab, with or without cobimetinib, in patients with …
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases [Phase 2]
Phase 2 trial evaluating crizanlizumab alone or with nivolumab for glioblastoma and melanoma brain metastases is currently recruiting at She…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Bevacizumab and ICIs + hSRT in Symptomatic Melanoma Brain Metastases [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating bevacizumab in combination with immune checkpoint inhibitors and hypofractionated stereotactic radi…
-
CLINICAL_TRIALS other · 2025-04-04Clinical Trial Update: A Study of Oral IRAK-4 Inhibitor CA-4948 in Combination With Pembrolizumab and Stereotactic Radiosurgery in Patients With Melanoma Brain Metastases [Phase 1, Phase 2]
A Phase 1/2 study of CA-4948 in combination with pembrolizumab and stereotactic radiosurgery for melanoma brain metastases is currently susp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Dabrafenib and Trametinib With Radiosurgery in Melanoma Brain Mets [Phase 2]
Phase 2 trial update on combining dabrafenib and trametinib with radiosurgery for BRAFV600E melanoma brain metastases; study terminated with…
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Phase II Study of Cobimetinib in Combination With Vemurafenib in Active Melanoma Brain Metastases [Phase 2]
Phase II trial of cobimetinib plus vemurafenib in patients with active melanoma brain metastases was terminated; results were posted in 2017…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated Boron Neutron Capture Therapy in patients with glioblastoma multiforme or melanoma brain metastases; th…